PFSCF Financials 07/15/2014 23:47:49 ProMetic Lif

PFSCF Financials 07/15/2014 23:47:49
ProMetic Life Sciences Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 19,430 23,422 17,274 11,506
Cost of Revenue 6,206 5,374 1,821 2,836
Gross Profit 13,224 18,048 15,453 8,670
Operating Expenses
Research and Development 17,468 10,466 11,029 11,944
Sales, General and Admin. 8,076 5,855 5,685 5,487
Non-Recurring Items - - 91 187
Other - - - 702
Operating Income (12,321) 1,726 (1,352) (9,650)
Income From Continuing Operations
Add'l Income/Expense Items (2,166) (665) (517) 74
Earnings Before Interest and Tax (14,551) 1,063 (1,489) (9,576)
Interest Expense 1,700 1,489 1,339 1,779
Earnings Before Tax (16,251) (426) (2,828) (11,355)
Income Tax 123 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary (65) 2 - -
Net Income Cont. Operations (16,838) (923) (3,208) (11,355)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (16,375) (426) (3,208) (11,355)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (16,375) (426) (3,208) (11,355)